GE HealthCare is a global leader in the Biotechnology and Health Care industries, offering intelligent devices, advanced analytics, and artificial intelligence to impact millions of lives every day. With a history dating back to 1997 and a workforce of approximately 50,000 employees worldwide, the company leverages over 100 years of industry experience to drive the digitization of healthcare, precision health, and improved patient outcomes. Positioned at the forefront of innovation, GE HealthCare is committed to facilitating faster, more informed decision-making for clinicians through its Edison intelligence platform. The company's commitment to creating a culture of respect, transparency, integrity, and diversity underpins its mission to push the boundaries of healthcare possibilities and drive positive change on a global scale.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Secondary | $1.07B | - | 16 Feb 2024 | |
| Grant | $44.00M | 1 |
|
18 Sep 2023 |
| Post-IPO Secondary | $1.95B | - | 07 Jun 2023 |
No recent news or press coverage available for GE HealthCare.
We care about your data, and we'd love to use cookies make your experience better.
